Novo Nordisk CEO Blames PBMs for Ozempic/Wegovy High Prices September 25, 2024 The spotlight on pharmaceutical giant Novo Nordisk shifted this week from Ozempic/Wegovy gastroparesis lawsuits to a grilling on the drugs’ prices. On Tuesday, the company’s CEO, Lars Fruergaard Jørgensen, faced intense scrutiny during a U.S. Senate hearing over the high cost of the company’s popular diabetes and weight-loss drugs. While senators criticized the corporation for […] Read More
Depo-Provera and Brain Tumor Risks: What You Need to Know About Meningioma Concerns September 24, 2024 Millions of women all over the world use Depo-Provera as a common hormonal birth control method. It works by delivering a synthetic form of progesterone, known as progestogen, into the body. While it’s an effective form of contraception, a recent study published in the British Medical Journal (BMJ) has uncovered a concerning link between prolonged […] Read More
Key Architect Behind $60 Billion Opioid Settlements Honored with AAJ Public Service Award August 27, 2024 Levin Papantonio (LP), the trailblazing mass torts law firm that has marched at the forefront of the national prescription opiates addiction litigation, is pleased to announce it has been awarded the American Association for Justice’s (AAJ) 2024 Steven J. Sharp Public Service Award, along with other member law firms of the Plaintiff Executive Committee (PEC) of this […] Read More
Levin Law